1. Home
  2. SLE vs CNSP Comparison

SLE vs CNSP Comparison

Compare SLE & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$4.06

Market Cap

5.6M

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$6.44

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
CNSP
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.9M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
SLE
CNSP
Price
$4.06
$6.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$60.00
$20.00
AVG Volume (30 Days)
11.1K
2.2M
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.03
EPS
N/A
N/A
Revenue
$2,064,000.00
N/A
Revenue This Year
$24.86
N/A
Revenue Next Year
$49.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
90.41
N/A
52 Week Low
$0.10
$0.73
52 Week High
$11.43
$10.59

Technical Indicators

Market Signals
Indicator
SLE
CNSP
Relative Strength Index (RSI) 57.20 72.34
Support Level $3.92 $5.62
Resistance Level $4.54 $8.73
Average True Range (ATR) 0.30 0.83
MACD 0.04 0.50
Stochastic Oscillator 95.30 54.98

Price Performance

Historical Comparison
SLE
CNSP

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: